martes, 4 de febrero de 2020

Journal of Experimental & Clinical Cancer Research | Articles

Journal of Experimental & Clinical Cancer Research | Articles

  • New Content Item
  • Owned by the Association for International Promotion & Study in Tumors (APSIT)
  • Regina Elena NCI
  • Official journal of the Regina Elena National Cancer Institute, Scientific Director Gennaro Ciliberto, Rome, Italy

  1. Sirtuin-7 (SIRT7) is associated with the maintenance of tumorigenesis. However, its functional roles and oncogenic mechanisms in prostate cancer (PCa) are poorly understood. Here, we investigated the roles and...
    Authors:Mao Ding, Chen-Yi Jiang, Yu Zhang, Jing Zhao, Bang-Min Han and Shu-Jie Xia
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:28
    Content type:Research
    Published on: 

  2. Hypoxia is a classic characteristic of the tumor microenvironment with a significant impact on cancer progression and therapeutic response. Hypoxia-inducible factor-1 alpha (HIF-1α), the most important transcr...
    Authors:Xiafeng Peng, Han Gao, Rui Xu, Huiyu Wang, Jie Mei and Chaoying Liu
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:27
    Content type:Review
    Published on: 

  3. Glioblastoma multiforme is a CNS cancer characterized by diffuse infiltrative growth, aggressive clinical behavior and very poor prognosis. The state-of-art clinical approach to this disease consists of surgic...
    Authors:Claudia Abbruzzese, Silvia Matteoni, Michele Persico, Veronica Villani and Marco G. Paggi
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:26
    Content type:Commentary
    Published on: 

  4. Metastasis and recurrence, wherein circulating tumour cells (CTCs) play an important role, are the leading causes of death in colorectal cancer (CRC). Metastasis-initiating CTCs manage to maintain intravascula...
    Authors:Qiong Huang, Shaowei Li, Xingbin Hu, Mengting Sun, Qijing Wu, Huiru Dai, Yujing Tan, Fei Sun, Chunlin Wang, Xiaoxiang Rong, Wangjun Liao, Jianjun Peng, Jianjun Xiao, Li Huang, Jiao Wang, Bishan Liang…
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:25
    Content type:Research
    Published on: 

  5. Hepatocellular carcinoma (HCC) is a common primary malignant tumor which usually progresses to an advanced stage because of late diagnosis. Sorafenib (Sora) is a first line medicine for advanced stage HCC; how...
    Authors:Jiao Feng, Weiqi Dai, Yuqing Mao, Liwei Wu, Jingjing Li, Kan Chen, Qiang Yu, Rui Kong, Sainan Li, Jie Zhang, Jie Ji, Jianye Wu, Wenhui Mo, Xuanfu Xu and Chuanyong Guo
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:24
    Content type:Research
    Published on: 

  7. The mechanism underlying sorafenib resistance in hepatocellular carcinoma (HCC) remains unclear. Accumulating evidence suggests that tumor-initiating cells (TICs) are a pivotal driving force. Both CD44 and Hed...
    Authors:Siqi Wang, Yang Wang, Xiaodong Xun, Changkun Zhang, Xiao Xiang, Qian Cheng, Shihua Hu, Zhao Li and Jiye Zhu
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:22
    Content type:Research
    Published on: 

  8. In the original publication of this article [1], the molecular weight of RBMS3 was incorrectly noted as 38 KDa within Fig 1A, Fig 2A and Fig 2B. The figures have been updated to list the correct molecular weig...
    Authors:Lei Zhu, Pei-Wen Xi, Xiao-Xia Li, Xi Sun, Wen-Bin Zhou, Tian-Song Xia, Liang Shi, Yue Hu, Qiang Ding and Ji-Fu Wei
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:21
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:105

  9. Exosomes play crucial roles in regulating the crosstalk between normal and cancer cells in the tumor microenvironment, and in regulating cancer proliferation, migration and invasion through their cargo molecules.
    Authors:Xiu-Yan Huang, Zi-Li Huang, Jin Huang, Bin Xu, Xin-Yu Huang, Yong-Hua Xu, Jian Zhou and Zhao-You Tang
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:20
    Content type:Research
    Published on: 

  10. In the original publication of this manuscript [1], Fig. 6 contains a repeated image in error (the left image of ‘Migration’ and the left image of ‘Invasion’).
    Authors:Yi-fang Lu, Jia-rui Yu, Zhao Yang, Guan-xia Zhu, Peng Gao, Huan Wang, Si-yuan Chen, Jie Zhang, Mei-yue Liu, Yi Niu, Xiao-mei Wei, Wei Wang, Feng-jin Ye, Li-xin Zhang, Yue Zhao and Guo-gui Sun
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:19
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:301

  11. Recently, the roles of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in human diseases have been unveiled, this research was conducted to explore the impacts of lncRNA SET-binding factor 2-antisense RN...
    Authors:Wenfei Xia, Yun Liu, Teng Cheng, Tao Xu, Menglu Dong and Xiaopeng Hu
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:18
    Content type:Research
    Published on: 

  12. STAT5 plays an important role in the transformation of hematopoietic cells by BCR-ABL. However, the downstream target genes activated by STAT5 in chronic myeloid leukemia (CML) cells remain largely unclear. He...
    Authors:Zi-Yuan Nie, Min Yao, Zhan Yang, Lin Yang, Xiao-Jun Liu, Jing Yu, Ying Ma, Nan Zhang, Xiao-Yan Zhang, Meng-Han Liu, Ling-Ling Jiang and Jian-Min Luo
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:17
    Content type:Research
    Published on: 

  13. Our previous study showed Musashi2 (MSI2) promoted chemotherapy resistance and pernicious biology of pancreatic cancer (PC) by down-regulating Numb and p53. We further explored the novel molecular mechanism in...
    Authors:Weiwei Sheng, Xiaoyang Shi, Yiheng Lin, Jingtong Tang, Chao Jia, Rongxian Cao, Jian Sun, Guosen Wang, Lei Zhou and Ming Dong
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:16
    Content type:Research
    Published on: 

  14. In the original publication of this manuscript [1], there are three errors in Fig. 1. The identified errors do not affect the conclusions of the work.
    Authors:Yongkui Li, Jie Shi, Shanshan Qi, Jian Zhang, Dong Peng, Zhenzhen Chen, Guobin Wang, Zheng Wang and Lin Wang
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:15
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:196

  15. In the original publication of this manuscript [1], the author mislabeled the CTL group and ZNF326 group in Fig. 2-I,J (MTT result). The revised Fig. 2 is shown below.
    Authors:Xinmiao Yu, Minghao Wang, Jingjing Wu, Qiang Han and Xiupeng Zhang
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:14
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:40

  16. Mps1 binding protein (MOB1) is one of the core components of the mammalian Hippo pathway and plays important roles in cancer development. However, its expression, function and regulation in pancreatic ductal a...
    Authors:Ming Quan, Zhiqin Chen, Feng Jiao, Xiuying Xiao, Qing Xia, Jingde Chen, Qian Chao, Yandong Li, Yong Gao, Haiyan Yang, Liwei Wang and Jiujie Cui
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:13
    Content type:Research
    Published on: 

  17. Histone lysine demethylase 4B (KDM4B) has been implicated in various pathological processes and human diseases. Glucose metabolism is the main pattern of energy supply in cells and its dysfunction is closely r...
    Authors:Haijie Li, Jingqin Lan, Guihua Wang, Kaixuan Guo, Caishun Han, Xiaolan Li, Junbo Hu, Zhixin Cao and Xuelai Luo
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:12
    Content type:Research
    Published on: 

  18. Mounting evidence suggests that complement components promote tumor progression via modulating immune suppression, angiogenesis, or tumor cell proliferation. However, the role of C3a-C3aR signaling in regulati...
    Authors:Chi Shu, Haoran Zha, Haixia Long, Xinxin Wang, Fei Yang, Jianbao Gao, Chunyan Hu, Li Zhou, Bo Guo and Bo Zhu
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:11
    Content type:Research
    Published on: 

  19. In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with ‘DMT1’ now corrected to read ‘DNMT1’.
    Authors:Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:10
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:474

  20. Localized C3 deposition is a well-known factor of inflammation. However, its role in oncoprogression of gastric cancer (GC) remains obscured. This study aims to explore the prognostic value of C3 deposition an...
    Authors:Kaitao Yuan, Jinning Ye, Zhenguo Liu, Yufeng Ren, Weiling He, Jianbo Xu, Yulong He and Yujie Yuan
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:9
    Content type:Research
    Published on: 

  21. Circular RNAs (circRNAs) have recently emerged as a new family of noncoding RNAs that are involved in the causation and progression of various cancers. However, the roles of circRNAs in the tumorigenesis of ga...
    Authors:Guangxu Deng, Tingyu Mou, Jiayong He, Da Chen, Daojun Lv, Hao Liu, Jiang Yu, Shuang Wang and Guoxin Li
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:1
    Content type:Research
    Published on: 

  22. Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy selecting a more malignan...
    Authors:Maria Carla Bosco, Gabriella D’Orazi and Donatella Del Bufalo
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:8
    Content type:Commentary
    Published on: 

  23. Long noncoding RNAs (lncRNAs) are involved in the progression of various cancers and affect the response to radiotherapy. This study focused on clarifying the underlying mechanism by which lncTUG1 affects the ...
    Authors:Pan Wang, Zhuanbo Yang, Ting Ye, Fei Shao, Jiagen Li, Nan Sun and Jie He
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:7
    Content type:Research
    Published on: 

  24. Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to c...
    Authors:Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, Silvia Careccia, Michele Signore, Tobias Longin Haas, Federico Salaris, Marta Baiocchi, Alessandra Boe, Alessandro Giuliani, Olga Tcheremenskaia, Alfredo Pagliuca, Ombretta Guardiola, Gabriella Minchiotti, Lidia Colace, Antonio Ciardi…
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:2
    Content type:Research
    Published on: 

  25. Recent evidence indicates that metformin inhibits mammalian cancer growth and metastasis through the regulation of microRNAs. Metformin regulates miR-381 stability, which plays a vital role in tumor progressio...
    Authors:Dan Jin, Jiwei Guo, Yan Wu, Weiwei Chen, Jing Du, Lijuan Yang, Xiaohong Wang, Kaikai Gong, Juanjuan Dai, Shuang Miao, Xuelin Li and Guoming Su
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:6
    Content type:Research
    Published on: 

  26. LncRNA LINC00662 is closely related to the occurrence and development of cancer. This study aims to explore the effect of LINC00662 on colon cancer tumor growth and metastasis and its molecular mechanism.
    Authors:Bo Cheng, Aimei Rong, Quanbo Zhou and Wenlu Li
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:5
    Content type:Research
    Published on: 

  27. MiR-199a-3p (miR-199a) can enhance the chemosensitivity of hepatocellular carcinoma (HCC). Because of the easy degradation of miRNA by direct infusion, effective vehicle-mediated delivery of miR-199a may repre...
    Authors:Guohua Lou, Liang Chen, Caixia Xia, Weina Wang, Jinjin Qi, Aichun Li, Liying Zhao, Zhi Chen, Min Zheng and Yanning Liu
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:4
    Content type:Research
    Published on: 

  28. Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women. Treatment with PARP inhibitors (PARPi), such as Olaparib, has been recently introd...
    Authors:Enrica Vescarelli, Giulia Gerini, Francesca Megiorni, Eleni Anastasiadou, Paola Pontecorvi, Luciana Solito, Claudia De Vitis, Simona Camero, Claudia Marchetti, Rita Mancini, Pierluigi Benedetti Panici, Carlo Dominici, Ferdinando Romano, Antonio Angeloni, Cinzia Marchese and Simona Ceccarelli
    Citation:Journal of Experimental & Clinical Cancer Research 2020 39:3
    Content type:Research
    Published on: 

  29. Circular RNA nuclear factor I X (circNFIX) has been reported to play an important role in glioma progression. However, the mechanism by which circNFIX participates in glioma progression remains poorly understood.
    Authors:Chenyu Ding, Zanyi Wu, Honghai You, Hongliang Ge, Shufa Zheng, Yuanxiang Lin, Xiyue Wu, Zhangya Lin and Dezhi Kang
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:506
    Content type:Research
    Published on: 

  30. Liver cancer stem cells (LCSCs) contribute to hepatocellular carcinoma (HCC) development, metastasis, and drug resistance. MSI2 and Notch1 signaling are involved in the maintenance of CSCs. However, it is unkn...
    Authors:Xiju Wang, Ronghua Wang, Shuya Bai, Si Xiong, Yawen Li, Man Liu, Zhenxiong Zhao, Yun Wang, Yuchong Zhao, Wei Chen, Timothy R. Billiar and Bin Cheng
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:505
    Content type:Research
    Published on: 

  31. MKK3 is a member of the dual specificity kinase group specific upstream activator of p38 MAPK proteins. We originally identified MKK3 as mutant p53 (mutp53) gain-of-function (GOF) upregulated target gene in di...
    Authors:Lorenzo Stramucci and Gianluca Bossi
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:504
    Content type:Commentary
    Published on: 

  32. The treatment of metastatic osteosarcoma (OS) remains a challenge for oncologists, and novel therapeutic strategies are urgently needed. An understanding of the pathways that regulate OS dissemination is requi...
    Authors:Cinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, Marianna Carrabotta, Sara Greco, Rosa Simona Pinca, Cristina Ferrari, Lorena Landuzzi, Michela Pasello, Pier-Luigi Lollini, Marco Gambarotti, Davide Maria Donati and Katia Scotlandi
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:503
    Content type:Research
    Published on: 

  33. Gastric cancer (GC) is one of the most prevalent and deadly malignancies worldwide. Accumulating reports have indicated the participation of long non-coding RNAs (lncRNAs) in the onset and progression of GC.
    Authors:Yangyang Dong, Xinyu Li, Zhibin Lin, Wenbing Zou, Yan Liu, Huiyang Qian and Jing Jia
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:502
    Content type:Research
    Published on: 

  34. Esophageal cancer is one of the most common malignant tumors in the world. With currently available therapies, only 20% ~ 30% patients can survive this disease for more than 5 years. TRAIL, a natural ligand fo...
    Authors:Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao and Baoen Shan
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:501
    Content type:Research
    Published on: 

  35. In the original publication of this article [1], the author found an error in Fig. 2f. lncGPR107 should be changed to lncMAPK6, and the corrected Fig. 2 is shown below.
    Authors:Guanqun Huang, Hui Jiang, Yueming He, Ye Lin, Wuzheng Xia, Yuanwei Luo, Min Liang, Boyun Shi, Xinke Zhou and Zhixiang Jian
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:500
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:105

  36. Mortalin is enriched in a large variety of cancers and has been shown to contribute to proliferation and migration of cancer cells in multiple ways. It has been shown to bind to p53 protein in cell cytoplasm a...
    Authors:Jayarani F. Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, Tomoko Yaguchi, Durai Sundar, Sunil C. Kaul and Renu Wadhwa
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:499
    Content type:Research
    Published on: 

  37. The MYCN amplification is a defining hallmark of high-risk neuroblastoma. Due to irregular oncogenes orchestration, tumor cells exhibit distinct fatty acid metabolic features from non-tumor cells. However, the...
    Authors:Yi Ding, Jie Yang, Yawen Ma, Tengteng Yao, Xingyu Chen, Shengfang Ge, Lihua Wang and Xianqun Fan
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:498
    Content type:Research
    Published on: 

  38. The survival of pancreatic cancer patients remains poor. However, the underlying molecular mechanism and new therapeutic target of pancreatic cancer are still needed to be found. Many studies have shown that t...
    Authors:Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv and Yuantin Gu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:497
    Content type:Research
    Published on: 

  39. In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.
    Authors:Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:496
    Content type:Correction
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:436

  40. Human bone marrow mesenchymal stem cells (hBMSCs) are implicated in cancer initiation and metastasis, sometimes by releasing exosomes that mediate cell communication by delivering microRNAs (miRNAs). This stud...
    Authors:Shuangjian Jiang, Chengqiang Mo, Shengjie Guo, Jintao Zhuang, Bin Huang and Xiaopeng Mao
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:495
    Content type:Research
    Published on: 

  41. Downregulation of microRNA-338-3p (miR-338-3p) was detected in many malignant tumors, which indicated miR-338-3p might serve as a role of antioncogene in those cancers. The present study aimed to explore the r...
    Authors:Ruitao Zhang, Huirong Shi, Fang Ren, Wei Feng, Yuan Cao, Gailing Li, Zheying Liu, Pengcheng Ji and Minghui Zhang
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:494
    Content type:Research
    Published on: 

  43. Molecular mechanisms driving acquired resistance to anti-EGFR therapies in metastatic colorectal cancer (mCRC) are complex but generally involve the activation of the downstream RAS-RAF-MEK-MAPK pathway. Never...
    Authors:S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello and T. Troiani
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:492
    Content type:Research
    Published on: 

  44. Growing evidence showed the increased prevalence of cancer incidents, particularly colorectal cancer, among type 2 diabetic mellitus patients. Antidiabetic medications such as, insulin, sulfonylureas, dipeptyl...
    Authors:Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou and Ishwar Parhar
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:491
    Content type:Review
    Published on: 

  45. N-myc downstream-regulated gene 1 (NDRG1) has been shown to play a key role in tumor metastasis. Recent studies demonstrate that NDRG1 can suppress tumor growth and is related to tumor proliferation; however, ...
    Authors:Sen Zhang, Chaoran Yu, Xiao Yang, Hiju Hong, Jiaoyang Lu, Wenjun Hu, Xiaohui Hao, Shuchun Li, Batuer Aikemu, Guang Yang, Zirui He, Luyang Zhang, Pei Xue, Zhenghao Cai, Junjun Ma, Lu Zang…
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:490
    Content type:Research
    Published on: 

  46. Ischemia reperfusion injury (IRI) has been shown to increase the risk of tumor recurrence after liver surgery. Also, nonalcoholic fatty liver disease (NAFLD) is associated with increased HCC recurrence. ALOX12...
    Authors:Faji Yang, Yuheng Zhang, Haozhen Ren, Jinglin Wang, Longcheng Shang, Yang Liu, Wei Zhu and Xiaolei Shi
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:489
    Content type:Research
    Published on: 

  47. Accumulating evidence indicates that aberrant microRNA (miRNA) expression contributes to osteosarcoma progression. This study aimed to elucidate the association between miR-624-5p expression and osteosarcoma (...
    Authors:Yongjun Luo, Wei Liu, Pengyu Tang, Dongdong Jiang, Changjiang Gu, Yumin Huang, Fangyi Gong, Yuluo Rong, Dingfei Qian, Jian Chen, Zheng Zhou, Shujie Zhao, Jiaxing Wang, Tao Xu, Yongzhong Wei, Guoyong Yin…
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:488
    Content type:Research
    Published on: 

  48. Arsenic sulfide was found to have potential anti-cancer activities, especially in gastric cancer. However, the underlying mechanism need to be further explored. This study was aimed to investigate the mechanis...
    Authors:Ting Kang, Maolin Ge, Ruiheng Wang, Zhen Tan, Xiuli Zhang, Chuanying Zhu, Han Liu and Siyu Chen
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:487
    Content type:Research
    Published on: 

  49. Gliomas are common life-threatening cancers, mainly due to their aggressive nature and frequent invasiveness and long non-coding RNAs (lncRNAs) are emerging as promising molecular targets. Therefore, we explor...
    Authors:Haiyang Xu, Guifang Zhao, Yu Zhang, Hong Jiang, Weiyao Wang, Donghai Zhao, Hongquan Yu and Ling Qi
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:486
    Content type:Research
    Published on: 

  50. Recent studies have reported that Integrin alpha 2 (ITGA2) plays an essential role in tumor cell proliferation, invasion, metastasis, and angiogenesis. An abnormally expressed ITGA2 correlates with unfavorable...
    Authors:Dianyun Ren, Jingyuan Zhao, Yan Sun, Dan Li, Zibo Meng, Bo Wang, Ping Fan, Zhiqiang Liu, Xin Jin and Heshui Wu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:485
    Content type:Research
    Published on: 
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)